CASI Pharmaceuticals, Inc. 4
4 · CASI Pharmaceuticals, Inc. · Filed Apr 8, 2015
Insider Transaction Report
Form 4
Ren Ken Keyong
Chief Executive Officer
Transactions
- Award
Stock Options(Right to Buy)
2015-04-06+225,000→ 225,000 totalExercise: $1.41Exp: 2025-04-06→ Common Stock (225,000 underlying)
Footnotes (1)
- [F1]The stock options vest as follows: 25% on the date of grant, and the remainder ratably over three years on a monthly basis.